The following profiles have been defined for this implementation guide:

* [BodyStructureIdentifier]
* [CancerDiseaseStatus]
* [CancerPatient]
* [CancerRelatedMedicationAdministration]
* [CancerRelatedMedicationRequest]
* [CancerRelatedSurgicalProcedure]
* [CancerStage]
* [CLLBinetStage]
* [CLLRaiStage]
* [Comorbidities]
* [ECOGPerformanceStatus]
* [GenomicRegionStudied]
* [GenomicsReport]
* [GenomicVariant]
* [GynecologicTumorFIGOStage]
* [HistoryOfMetastaticCancer]
* [HumanSpecimen]
* [KarnofskyPerformanceStatus]
* [LymphomaStage]
* [mCODEPatientBundle]
* [mCODEPatientGroup]
* [MelanomaBreslowDepthStage]
* [MelanomaClarkLevel]
* [MyelomaISSStage]
* [MyelomaRISSStage]
* [PrimaryCancerCondition]
* [ProstateGleasonGradeGroup]
* [RadiotherapyCourseSummary]
* [RadiotherapyVolume]
* [SecondaryCancerCondition]
* [TNMDistantMetastasesCategory]
* [TNMPrimaryTumorCategory]
* [TNMRegionalNodesCategory]
* [TNMStageGroup]
* [Tumor]
* [TumorMarkerTest]
* [TumorSize]

The following draft (maturity level 0) profiles have been defined for this implementation guide:

* [ALLRiskAssessment]
* [BodySurfaceArea]
* [CancerResearchSubject]
* [CancerRiskAssessment]
* [HistologicBehaviorAndType]
* [HistologicGrade]
* [LanskyPlayPerformanceScale]
* [MedicalHistory]
* [NeuroblastomaINRGSSStage]
* [NeuroblastomaINSSStage]
* [ProstateGleasonGradeGroup]
* [RhabdomyosarcomaClinicalGroup]
* [RhabdomyosarcomaRiskAssessment]
* [TumorMorphology]
* [WilmsTumorStage] 

{% include markdown-link-references.md %}
